Note to myself: The resources I reviewed today are listed below. Although very interesting, I don’t believe I need to review them again. If I do want to review the mechanisms of SGLT2 Inhibitors, the best way would be to listen to The Curbsiders‘ Episode #204 podcast while driving in the car. To that end I’ve embedded the podcast here:
Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a new group of oral medications used for treating type 2 diabetes The drugs work by helping the kidneys to lower blood glucose levels.
The following drugs belong to the SGLT2 inhibitors class (trade name first, generic name in brackets):
In this post I review some resources on SGLT2 Inhiitors.
And I’ve reviewed the following:
- #204 NephMadness 2020: SGLT2 Inhibitors
APRIL 6, 2020 By HANNAH ABRAMS from The Curbsiders [Link is to the episode list].
- #NephMadness 2020: SGLT2i Region. Posted on March 13, 2020 by in NephMadness. By Dr Harish Seethapathy @BetterCallSeeth
Excerpts from the above coming soon.